Understanding VTE Risk in Ambulatory Cancer Patients: Just Beginning to Scratch the Surface
David Henry: Understanding VTE Risk in Ambulatory Cancer Patients: Just Beginning to Scratch the Surface
20100001
2010 Jan 1
Top Stories of 2009
Understanding VTE Risk in Ambulatory Cancer Patients: Just Beginning to Scratch the Surface
Top Stories of 2009. 2010 Jan 1
Dr. David Henry is Clinical Professor of Medicine, Pennsylvania Hospital. View profile. 1. In your view, which development that occurred in 2009 could have the most significant impact on oncology practice?From my perspective, the top story of 2009 is not a new advance per se. Rather, the key development is oncologists’ increased awareness that ambulatory patients with cancer who are treated with chemotherapy are at a markedly elevated risk of experiencing a venous thromboembolism (VTE). Regardless...